Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cardiol Therapeutics Inc. (CRDL.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
2.2700-0.1000 (-4.22%)
At close: 04:00PM EST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.3700
Open2.3500
Bid2.2600 x 0
Ask2.2700 x 0
Day's Range2.2300 - 2.3600
52 Week Range1.9700 - 6.1900
Volume194,525
Avg. Volume319,457
Market Cap134.603M
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-0.9300
Earnings DateAug 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.66
  • Newsfile

    Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board

    Oakville, Ontario--(Newsfile Corp. - January 19, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease, today announced the appointment of Paul M. Ridker, MD, MPH, Bruce McManus, PhD, MD, and Joseph A. Hill, MD, PhD, to its Scientific Advisory Board (SAB). "We are pleased to welcome distinguished th

  • Newsfile

    Cardiol Therapeutics Announces Closing of US$50 Million Public Offering

    Oakville, Ontario--(Newsfile Corp. - November 5, 2021) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing anti-inflammatory therapies for the treatment of cardiovascular disease, announced today the closing of its previously announced public offering (the "Offering") of 16,350,000 units of the Company (the "Units") at a price to the public of US$3.07 per Unit for gross proceeds of US$50,194,500, before

  • Simply Wall St.

    What You Need To Know About Cardiol Therapeutics Inc.'s (TSE:CRDL) Investor Composition

    The big shareholder groups in Cardiol Therapeutics Inc. ( TSE:CRDL ) have power over the company. Large companies...

Advertisement
Advertisement